These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2010311)

  • 1. Clinical studies with B72.3 in ovarian cancer and probe-guided tumor localization.
    Del Vecchio S; Camera L; Petrillo A; Esposito G; Frasci G; Iaffaioli RV; Bianco AR; Salvatore M
    Int J Rad Appl Instrum B; 1991; 18(1):85-7. PubMed ID: 2010311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of therapeutic response using iodine-131-B72.3 monoclonal antibody in patients with ovarian carcinoma.
    Camera L; Del Vecchio S; Petrillo A; Esposito G; Frasci G; Iaffaioli RV; Bianco AR; Salvatore M
    Eur J Nucl Med; 1991; 18(4):269-73. PubMed ID: 2070805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of ovarian cancer with radiolabelled monoclonal antibodies: our experience using 131I-B72.3.
    Mansi L; Panza N; Lastoria S; Pacilio G; Salvatore M
    Int J Rad Appl Instrum B; 1989; 16(2):127-35. PubMed ID: 2715006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative radioimmunodetection of ovarian cancer using monoclonal antibody B72.3 and a portable gamma-detecting probe.
    Bell J; Mojzisik C; Hinkle G; Derman H; Schlom J; Martin E
    Obstet Gynecol; 1990 Oct; 76(4):607-11. PubMed ID: 2216188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CA125 and radioimmunoimaging in monitoring of epithelial ovarian carcinoma].
    Yu Q; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 1991 Jul; 26(4):235-8, 252. PubMed ID: 1914661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization and imaging of radiolabeled monoclonal antibodies against colorectal carcinoma in tumor-bearing nude mice.
    Buchsbaum D; Lloyd R; Juni J; Wollner I; Brubaker P; Hanna D; Spicker J; Burns F; Steplewski Z; Colcher D
    Cancer Res; 1988 Aug; 48(15):4324-33. PubMed ID: 3390828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution, pharmacokinetics and imaging of 131I-labelled OC125 in ovarian cancer.
    Haisma HJ; Moseley KR; Battaile AI; Griffiths TC; Zurawski VR; Knapp RC
    Int J Cancer Suppl; 1988; 2():109-13. PubMed ID: 3162437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoscintigraphy in patients with ovarian cancer.
    Kalofonos HP; Karamouzis MV; Epenetos AA
    Acta Oncol; 2001; 40(5):549-57. PubMed ID: 11669325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary diagnosis and follow-up of ovarian cancer: radioimmunoscintigraphy with iodine-131 labeled OC 125 monoclonal antibodies versus computed tomography and "second look".
    Barzen G; Hierholzer J; Cordes M; Friedmann W; Felix R
    Int J Rad Appl Instrum B; 1991; 18(1):69-76. PubMed ID: 2010310
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical value of radioimmunoscintigraphy in the follow-up of ovarian carcinoma: a prospective study.
    Crippa F; Presti M; Marini A; D'Onofrio B; Bolis G; Buraggi GL
    Int J Biol Markers; 1990; 5(3):103-8. PubMed ID: 2286774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective imaging study of 131I-B72.3 monoclonal antibody in patients with epithelial ovarian cancer: preliminary report.
    Lastoria S; D'Amico P; Mansi L; Giordano GG; Rossiello R; Schlom J; Pace E; Panza N; Pacilio G; Salvatore M
    Nucl Med Commun; 1988 May; 9(5):347-56. PubMed ID: 2842708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures.
    Xu FJ; Yu YH; Daly L; DeSombre K; Anselmino L; Hass GM; Berchuck A; Soper JT; Clarke-Pearson DL; Boyer C
    J Clin Oncol; 1993 Aug; 11(8):1506-10. PubMed ID: 8336189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical immunoscintigraphy of ovarian carcinoma using iodine-131-labeled 145-9 monoclonal antibody.
    Chung JK; Kang SB; Lee HP; Lee MC; Koh CS; Sakahara H; Endo K
    J Nucl Med; 1993 Oct; 34(10):1651-5. PubMed ID: 8410277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OC125 immunoscintigraphy in ovarian carcinoma: a comparison with alternative methods of assessment.
    Maughan TS; Haylock B; Hayward M; Facey P; Evans WD; Shelley MD; Fish RG; Adams M
    Clin Oncol (R Coll Radiol); 1990 Jul; 2(4):199-205. PubMed ID: 2261415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
    Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
    J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The detection of metastases of ovarian carcinoma by immunoscintigraphy with monoclonal antibodies].
    Peking A; Marinov V
    Akush Ginekol (Sofiia); 1990; 29(1):57-60. PubMed ID: 2164792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-antigen complex formation following injection of OC125 monoclonal antibody in patients with ovarian cancer.
    Haisma HJ; Battaile A; Stradtman EW; Knapp RC; Zurawski VR
    Int J Cancer; 1987 Dec; 40(6):758-62. PubMed ID: 3480271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoscintigraphy with 131I or 111In labelled OC 125 F(ab')2 fragments in patients with ovarian carcinoma.
    Jiménez-Vicioso A; Torres M; Jiménez-Heffernan A; Grana MD; Latre JM; Llamas JM; Carreras JL; Mateo A
    Int J Biol Markers; 1990; 5(4):159-65. PubMed ID: 2093731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoscintigraphy of recurrences of gynecologic carcinomas.
    Chatal JF; Fumoleau P; Saccavini JC; Thedrez P; Curtet C; Bianco-Arco A; Chetanneau A; Peltier P; Kremer M; Guillard Y
    J Nucl Med; 1987 Dec; 28(12):1807-19. PubMed ID: 3500284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of radioimmunoscintigraphy compared to computed tomography in the diagnosis and follow-up of primary ovarian carcinoma].
    Barzen G; Cordes M; Langer M; Friedman W; Mayr AC; Felix R
    Rofo; 1990 Jul; 153(1):85-91. PubMed ID: 2166319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.